Introduction and is likely to be an integral membrane glycoprotein that regulates cell-cell or cell-matrix interactions. PKD2 Autosomal dominant polycystic kidney disease (ADPKD) encodes a 5.4 kb mRNA within ‫86ف‬ kb of genomic DNA is one of the most common inherited diseases of hu- (Mochizuki et al., 1996) . The predicted protein of 968 mans; it is estimated to affect 1 in 1000 of the population amino acids has significant homology to the voltage- (Gabow, 1993) . Renal cysts are the major clinical feaactivated Ca 2ϩ channel ␣1E as well as to a portion of tures of the disease and appear to increase in size and polycystin. It is thought to encode an integral membrane number throughout the lifetime of an individual. This protein that may function as an ion channel or pore process results in renal failure in approximately half of whose activity is regulated by polycystin. Neither gene affected individuals by age 50 years. Although the renal has any trinucleotide repeats within its mRNA that are lesion is the most prominent feature, ADPKD is a sys->5 units in length, nor are any found within the complete temic disorder with a variety of other manifestations gene sequence of PKD1. including liver cysts, cerebral aneurysms, and a variety Mutation analysis of PKD1 has been greatly hindered of cardiac valvular abnormalities.
by high sequence similarity to its replicated loci. None-ADPKD exhibits considerable variability with respect theless, the mutations reported to date for both PKD1 to both its renal and extrarenal manifestations. Genetic and PKD2 have been stable nucleotide substitutions, heterogeneity is likely to account for at least some of deletions, or insertions and do not explain why family these differences. Linkage studies have determined that members with the same germline mutation exhibit drathere are at least three forms of ADPKD. PKD1, which is matic phenotypic variability (Peral et al., 1995 (Peral et al., , 1996a , most common and accounts for 85%-95% of all cases, 1996b; Mochizuki et al., 1996) . In fact, Peral et al. (1996b) maps to chromosome 16p13.3 (Reeders et al., 1985) .
recently reported a set of fraternal twins with the same The second type, PKD2, which affects most of the regermline nonsense mutation in PKD1 yet with remarkmaining families, maps to chromosome 4q13-23 (Kimably different phenotypes. One child had a severe infanberling et Peters et al., 1993) . A small number tile-onset form of the disease, whereas the other had of families have another form, which has not yet been no cysts at the age of 5 years. The authors suggested mapped (Bogdanova et al., 1995; Daoust et al., 1995;  that the difference in clinical presentation was most likely due to the effect of a small number of genetic modifying factors. (A) Cystic epithelia were isolated from 11 intact cysts (1-11) from donor JHU93. Male genomic DNA (() was added to an aliquot of each cyst-derived DNA sample as well as DNA isolated from the donor's nucleated blood cells. One half of each mix was digested with HpaII and then used as template for PCR using the androgen receptor primers AR1 and AR2. The amplification products are presented in lanes labeled ϩ. The other undigested half of each mix was used as template for a control amplification done in parallel using identical reaction conditions. The results are presented in lanes labeled Ϫ. The symbols to the left of the figure identify the position of the AR alleles of the donor (&) and male control. Three bands are present in the Ϫ lanes of all samples except for that which had only male DNA as template (() and cyst 9, which yielded no products. All samples derived from cysts yielded a single band after digestion if the reaction was complete (cysts 2, 4, 5, 6, 8, and 11) . In contrast, DNA from blood of the donor yielded two bands despite complete digestion with HpaII prior to PCR. The clonal status of samples 1, 3, and 7 were deemed uninterpretable because of incomplete digestion. (B) Sixteen intact cysts (C1-16) from donor JHU273 were analyzed using a protocol similar to that described above. Each mix of male-and cyst-derived DNA was digested with HhaI rather than HpaII prior to amplification using AR1 and AR2. Both the final rinse (w) and fluid containing the cyst-lining epithelial cells (c) were evaluated for each sample. For C1 and C2, the original cyst fluid (f) was similarly examined. A dilution series of DNA prepared from nucleated blood cells of JHU273 was analyzed using an identical procedure (right). These data suggest that a minimum of 2.5 ng of cyst DNA was used as template for each amplification. Assuming that the average cell contains ‫01ف‬ pg of DNA and one tenth of the total yield of cyst DNA was used for each reaction, each sample was estimated to contain between 2500 and 500,000 cells. cystic disease support a role for the effect of other loci in al., 1987) . Recently, a polymerase chain reaction (PCR)-based clonality assay has been developed that can be disease expression, genetic background probably does not explain all aspects of phenotypic variability in human used for small quantities of template (Gilliland et al., 1991) . This method exploits methylation-sensitive re-ADPKD (Iakoubova et al., 1995) . Even within a single kidney, fewer than 1% of nephrons actually develop striction sites (HpaII and HhaI) close to the highly polymorphic (CAG) n repeat in the X-linked androgen receptor cysts, suggesting that cystogenesis is a focal process. Histopathologic studies of ADPKD kidneys have congene. The methylation status of these sites correlates with X-inactivation (Allen et al., 1992) . Willman et al. firmed that cyst formation begins with the localized outgrowth of a tubule in any nephron segment, including (1994) used this approach to show the monoclonal nature of histiocystosis X. We have modified this technique segments with different embryologic origins (Evan and McAteer, 1992; Schä fer et al., 1994) . These observations to determine the clonality of single cysts in ADPKD kidneys. suggest that cyst formation is a two-step process and that an inherited mutation at one of the ADPKD gene Initial studies using DNA prepared from large specimens (>5 g) containing multiple cysts failed to detect loci is necessary but insufficient for cystogenesis.
We have hypothesized that the focal nature of cyst monoclonality (data not shown). We then attempted to isolate the epithelial cells lining a single cyst using microformation in ADPKD probably holds clues to an understanding of the pathogenesis of this disorder. To study dissection. Again, most samples were polyclonal, but histologic analysis revealed that the microdissected this process, we have developed a novel method for isolating epithelial cells from single renal cysts that minispecimens were in fact multilayered structures with multiple nonepithelial cellular elements (data not shown). mizes contamination by other cells and have used it to show that renal cysts in ADPKD are monoclonal. We
To circumvent these difficulties we adapted a method previously used to study toad bladder epithelia (Handler have demonstrated loss of heterozygosity (LOH) within individual cysts for two closely linked polymorphic market al., 1979) and applied it to the isolation of cyst-lining cells. In this method, the cyst remains intact during the ers located within the PKD1 gene. Genetic analysis has confirmed that it is the normal haplotype that is lost in entire procedure. EDTA injected into the cyst lumen is used to dissociate the epithelial cells from the underlying somatic tissues. This study provides a molecular explanation for the focal nature of cyst formation and a probabasement membrane, which serves as a natural barrier to contaminating cells. ble mechanism whereby mutations cause disease.
Results of the clonality assay of cysts isolated from two individuals with ADPKD are presented in Figure 1 Results as representative examples. Of the 11 samples that were prepared from individual cysts of donor JHU93 ( Figure  Renal Cysts in ADPKD Are Monoclonal X-chromosome inactivation has been commonly used 1A), two failed to yield sufficient product for analysis (samples 9 and 10). The results of three other samples to demonstrate the clonal nature of tumors (Fearon et were deemed uninterpretable because of incomplete digestion (samples 1, 3, and 7). The remainder (samples 2, 4, 5, 6, 8, and 11) yielded a single product after digestion. Samples prepared from 16 individual cysts of donor JHU273 were similarly analyzed ( Figure 1B) . The clonal status of three samples could not be determined because their final rinse solutions also yielded PCR products (C3 and C15) or because no PCR product was detected (C5). Of the remaining 13 cysts, 11 (85%) yielded a single PCR product after HhaI digestion. Only 2 of the 13 cysts (C6 and C14) yielded two products, and in each instance the bands were of unequal intensity, suggesting a clonal bias. that the rinse solution of approximately one half of the The PCR product that contains KG8 and EJ1 is approximately 1.6 kb in length and is generated using FQF28 and KG8R8.
apparently polyclonal cysts yielded PCR products, suggesting probable contamination (Figure 1 ). The small number of cysts that are truly polyclonal may have resulted from the fusion of two or more formerly neighband for KG8. Figure 3A is a representative example of data using these markers. Two cysts from this kidney boring monoclonal cysts.
(C8 and C14) were found to have LOH. A total of 46 cysts from four donors were evaluated with KG8, and Allelic Loss of a PKD1 Intragenic Microsatellite, KG8 It is possible that cysts may develop from a cluster 17% were found to be hemizygous for this marker (Table  1) . At least two cyst preparations per donor had loss of of cells sharing a common X-chromosome inactivation status rather than from clonal expansion of a single a KG8 allele, and in each case it was the same allele. progenitor cell. To prove that renal cysts are truly monoclonal and to investigate the molecular basis of clonality,
Loss of a Second Closely Linked Marker, EJ1
We sought to confirm the KG8 results using a second we tested for LOH for PKD1 in individual cysts using the microsatellite KG8 (Snarey et al., 1994) . This marker marker that was either intragenic or immediately proximal to PKD1, but the closest known highly polymorphic lies within the 3Ј untranslated region (3ЈUTR) of the PKD1 mRNA ( Figure 2 ). Two alleles were equally amplified in marker was at least 70 kb away. In the course of performing mutation analyses, we discovered a polymormost samples. In a subset, however, only a single band was amplified. We included primers for the androgen phic locus, EJ1, in exons 45-46 that is located approximately 1.6 kb proximal to KG8 (Figure 2 ). It has at least receptor as an internal control. Two bands corresponding to the androgen receptor alleles were equally amplithree allelic variants (A1-A3) that can be detected using heteroduplex analysis. We used this marker to test for fied in all samples, including those that had a single A 1.6 kb PCR fragment containing KG8 and EJ1 was amplifed from blood and then cloned ( Figure 2 ). Individual clones were assayed for their respective KG8 (A) and EJ1 alleles (B). Clones were assigned an EJ1 allele based on mixing studies with unlabeled A1 (B) and A2 (data not shown). All clones contained either KG8 allele 110 bp and EJ1 allele A1 (clones 1 and 3) or KG8 allele 106 bp and EJ1 A2 allele (clones 2, 4, and 5). nt, length in nucleotides.
that cyst samples isolated from the same donor had loss of an identical allele ( Figure 3C ). A total of 30 cysts from three donors were evaluated with this marker, and 7 were found to have either a deletion or novel somatic mutation involving this locus (Table 1) .
Loss of the Unaffected Haplotype
The concordance between the KG8 and EJ1 data strongly suggested that the lost alleles belong to the all donors was found to be lost in the samples.
C8 and C14, however, demonstrate LOH at this locus since hetero-
We next sought to determine whether it was the norduplex formation is no longer present. C12 shows a novel heteromal or affected haplotype that was lost in cystic tissue.
duplex pattern.
Linkage analysis using KG8 and 3ЈHVR was performed (C) Mixing studies were performed to determine which EJ1 allele remained in cyst samples with apparent LOH (C8 and C14) or a novel on the only two families available for testing. 3ЈHVR was heteroduplex pattern (C12). Samples with patterns representative of linked to the disease in these families, with maximum blood (C2 and C15) were included as controls. Unlabeled EJ1 alleles lod scores of 1.34 (pedigree 1, Figure 5A ) and 2.18 (pedi-A1, A2, and A3 were mixed separately with radiolabeled EJ1 that had gree 2, Figure 5B ) at a recombination fraction of 0.0. A been amplified from each cyst and then analyzed for heteroduplex positive lod score (1.93) was also obtained with KG8 in formation. The addition of A1 did not alter the preexisting heteropedigree 2. While linkage of ADPKD to KG8 was only duplex patterns of any of the cysts, whereas the addition of A3 resulted in a novel pattern in cysts without LOH. Although mixing weakly positive in pedigree 1 (maximum lod score of with A2 did not change the patterns for C2 and C15, it restored the 0.32), two-point analysis of 3ЈHVR and KG8 favored the control heteroduplex pattern in C8 and C14 and yielded a unique haplotype shown in Figure 5A (maximum lod score of band in C12. These results suggest that A1 is present in all cysts, 0.99 at a recombination fraction of 0.0). These results whereas A2 has been lost from C8 and C14 and replaced by a novel strongly sugest that it was the chromosome 16 haploallele in C12. A3 is missing from all cysts because this allele is not type not associated with disease that was lost in cystic present in JHU273.
tissue (Figure 5).
A Novel Somatic Mutation LOH in cysts from donors known to be polymorphic at this locus. There was complete concordance between One cyst sample was discovered to have discordant results with KG8 and EJ1. This sample (C12) did not have the studies using KG8 and EJ1, with one exception (discussed below) ( Figure 3B ). All samples that lacked a loss of a KG8 allele but did have a unique heteroduplex pattern with EJ1 (Figure 3 ). Mixing studies determined KG8 allele also lacked one for EJ1. Mixing studies (see Experimental Procedures) were used to demonstrate that the A2 allele of EJ1, which was lost in the other two PKD1 is linked to 3ЈHVR and KG8 with maximum lod scores of 1.34 and 0.32, respectively, at a recombination fraction of 0.0 for both markers in pedigree 1 (A). The posterior probability of linkage of the disease in this family to PKD1 is >95%. Two-point analysis of 3ЈHVR Figure 6 . A 2 bp Deletion in C12 (⌬C12) Creates a Novel MwoI Site and KG8 favors the haplotype shown in (A). In pedigree 2 (B), the (A) EJ1 was amplified from C12, and clones of two alleles (A1 and maximum lod scores for 3ЈHVR and KG8 are 2.18 and 1.93, respec-A4) were identified. The sequence of the novel allele, A4, is shown tively, at a recombination fraction of 0.0. The genotypes D,110 and along with the corresponding sequence of A1. A4 contains a 2 bp A,110 segregate with ADPKD in pedigree 1 (A) and pedigree 2 (B), deletion (underlined in A1) that creates a new MwoI site (arrow). The respectively. In each kidney donor (arrows), it is the KG8 allele that deletion was confirmed by analysis of two clones sequenced in both does not segregate with disease which is lost in cysts demonstrating orientations. LOH. subfragment of A1 and A4. Cleavage at the new site is predicted to result in two fragments of nearly identical length in A4.
(C) To confirm that the DC12 deletion was a somatic mutation, the cysts (C8 and C14) from this donor, had been replaced 172 bp subfragment was amplified from the following templates:
by a novel allele (A4) in C12. We cloned both the A1 DNA isolated from peripheral blood of JHU273 (lanes 1 and 2) and and A4 alleles of the EJ1 locus from this sample and cloned alleles A1 (lanes 3 and 4) and A4 (lanes 5 and 6) as well as determined the sequence of the novel allele ( Figure 6A ).
from the original EJ1 PCR product (lanes 7 and 8). Undigested
Comparison of the sequence of A4 to that of A1 revealed products (lanes 1, 3, 5, and 7) and products digested with MwoI (lanes 2, 4, 6, and 8) were analyzed on a 4% Nusieve gel. As pretwo differences. The first is a 2 bp deletion (⌬C12) at in the sequence of either the A1 or A2 alleles of EJ1 ( Figure 6B ). This site was used to confirm the presence of the deletion in the original C12 DNA sample ( Figure 6C ). The donor's blood DNA lacks the restriction site, examined. We cannot determine whether the two cysts with LOH for KG8 had identical mutations or were indeproving that the mutation was acquired and not present in the donor's germline. The second difference in the pendent events since they had identical X-chromosome inactivation patterns. Cysts from other kidneys, how-A4 sequence is a C-to-T transition at position 12,617, which has no effect on the protein sequence. This is the ever, that had a similar pattern of LOH for PKD1 markers had different X chromosomes inactivated, suggesting same sequence variant associated with the A2 allele, suggesting that the ⌬C12 deletion occurred on this that independent events had resulted in LOH (data not shown). Formal proof of our hypothesis must await the background.
development of methods that can be used for mutation analysis of the full length of the PKD1 gene.
Discussion
The very high rate of somatic mutation predicted by our model is surprising since no known dynamic ele-A notable but unexplained clinical feature of all forms of ments have been identified within the genomic se-ADPKD is the phenotypic variability exhibited by family quence of PKD1 and since the adult kidney is thought members who share a common mutation. The focal nato have a relatively low mitotic index. However, we have ture of renal cysts is an extreme example of this variabilpreviously reported an extremely unusual 2.5 kb polyity since all renal tubular epithelial cells within a kidney pyrimidine tract within intron 21 that may be responsible have an identical mutation. These features suggest that for the gene's increased rate of mutation (The American other factors are required for cyst formation. Identifica-PKD1 Consortium, 1995). Similar but much shorter eletion of these other components may explain the pathoments present within other genes have been shown to genesis of the disease and possibly provide new aveundergo triple-helix formation both in vitro (Young et al., nues for developing therapies.
1991) and in vivo (Rao et al., 1988) . Wang et al. (1996) To evaluate the molecular mechanisms responsible recently have shown that triplex formation induces for cystogenesis, we developed a novel method for isomutagenesis in a mammalian cell culture system and lating epithelial cells from individual cysts. This techdemonstrated a requirement for excision and transcripnique minimizes contamination from other cell types and tion-coupled repair in this process. The authors hypothavoids biases resulting from the use of cultured cells.
esized that formation of the triple helix causes a stall We have used this approach to analyze multiple kidneys in transcription that triggers gratuitous and potentially from females and have shown, using two independent error-prone repair. They proposed that naturally ocmethods, that renal cysts in ADPKD are clonal in origin.
curring triple helices may similarly trigger repair and Our data suggest that somatic mutation of the previously mutagenesis and thus constitute endogenous sources normal PKD1 allele is the second, rate-limiting step in of genetic instability. cystogenesis and is likely to account for the focal formaWe postulate that the polypyrimidine tract within tion of renal cysts. The rate at which one acquires these PKD1 may cause ongoing errors in its transcription-"second hits" probably plays a major role in determining coupled repair that result in a high frequency of somatic the course of disease and probably explains much of mutation. This model can explain the multiplicity of secits phenotypic variability. It may be speculated that a ond hits as well as the apparent development of new similar two-hit mechanism may also be responsible for cysts throughout the lifetime of an individual. Likewise, causing the extrarenal manifestations of PKD1.
the genetic instability possibly associated with this unLoss of the normal allele of PKD1 in cystic tissue usual genomic structure may be responsible for the high suggests a molecular recessive mechanism of disease incidence of PKD1 within the population. If this element similar to that seen with numerous tumor suppressor is proven to be responsible for the gene's mutability, genes. If our model is correct, however, the frequency PKD1 will be the first example of a disease that results of "second hits" in cystic epithelia must be extremely from this novel mechanism of somatic mutation. high to account for the thousands of cysts that are obThe indistinguishable clinical presentation of patients served. This is in contrast to the small number of tumors with PKD2 suggests a two-step process in this disease found in other inherited disorders of the kidney in which as well. Whereas the initial step is certainly a germline somatic mutation of the normal allele is required for mutation of PKD2, the nature of the second event is not disease. Wilms' tumor (Huff et al., 1991) and von Hippel yet known. Presently it cannot be excluded that there Lindau's disease (Foster et al., 1994) are representative may be an uncharacterized unstable element hiding examples.
within the genomic structure of PKD2 that results in Our data suggest that there is indeed a high rate of frequent somatic inactivation in a manner analogous to somatic mutation in PKD1. This is best illustrated by that of PKD1. The relative infrequency of PKD2 argues sample JHU273 (Table 1) . Of the 13 cysts that were against this hypothesis, however. The phenotypic simishown to be monoclonal, 2 had loss of alleles for KG8 larity of the disorders may offer an alternative hypotheand EJ1; 1 had a unique 2 bp deletion; and 8 had no sis. Investigators have postulated that the gene proddetectable mutation of the normal allele. The last group ucts of PKD1 and PKD2 may be interacting partners of did not have a common X-chromosome inactivation pata common pathway. It has been suggested that the tern, suggesting that they had arisen from at least two function of PKD1 may be to regulate the activity of PKD2 independent progenitor cells (Figure 1 ). Assuming that (Mochizuki et al., 1996) . If this is correct, somatic inactithe somatic mutations arose after X-chromosome inactivation of PKD1 may be the second step that leads to vation was completed, a minimum of four independent clonal expansion in PKD2 and possibly other forms of ADPKD. This model predicts that the frequency with mutations must have occurred in the 13 cysts that were was added to each cyst DNA sample prior to PCR to control for the which cysts form in PKD1, PKD2, and PKD3 will be completeness of HpaII or HhaI digestion. In most cyst samples, determined by the rate of somatic mutation of PKD1.
the male-specific product was not amplified after HpaII or HhaI
The identical number of renal cysts observed in the three digestion, as expected. disorders is consistent with this hypothesis.
In this study, we have determined that random inacti-
Loss of Heterozogosity Assay Using KG8
vation of the normal PKD1 allele in somatic tissue is the
The microsatellite KG8 that is present in the 3ЈUTR of PKD1 mRNA likely molecular explanation for the observed clinical was used to distinguish the mutant and normal alleles (Snarey et variability and the focal formation of renal cysts in the al., 1994). Cystic DNA samples served as template for PCR amplification. PCR amplification was performed for 28 cycles using an most common form of ADPKD. Both the high incidence identical protocol as that used for the androgen receptor except of the disease in the population and the large number that the reaction included a final concentration of 1 M of each KG8
of second hits that must occur to account for the num- P-end-labeled KG8F8, and 1.5 mM MgCl2. The PCR products were diluted with 5ϫ volume of sequencing loading buffer and sepamechanism of disease since both alleles are mutated in rated in a 6% denaturing polyacrylamide gel. The dried gel was renal cysts. These findings have important implications examined by autoradiography using X-Omat XAR film (Kodak) at for investigators interested in developing models sys-Ϫ80ЊC overnight with an intensifying screen.
tems and suggest that treatment strategies directed at replacement of polycystin may prevent cyst formation
Heteroduplex Analysis
and end-stage renal disease.
Either 200 ng of genomic DNA (isolated from whole blood using the Puregene kit) or 5 l of cyst DNA was used as template for amplification of a 540 bp product (EJ1) using primers FQF28 Experimental Procedures (5Ј-CACGCCTTGCGTGGAGAG-3Ј, 12,539-12,556; HUMPKD1A) and FQR35 (5Ј-ATGGGCCACGGGAAGATCC-3Ј, 12,977-12,995). PCR Preparation of Cystic Epithelial Cells from a Single Cyst was performed as follows: denaturation at 94ЊC for 5 min; 35 cycles Cystic kidneys were processed within 24 hours of removal from the of 94ЊC for 30 sec, 62ЊC for 30 sec, and 72ЊC for 30 sec; and a final patient and were maintained at 4ЊC. The surface of the cyst was extension of 72ЊC for 10 min. The total PCR volume was 30 l using first rinsed with PBS and then its contents were drained by needle 2 units of Taq DNA polymerase (Boehringer Mannheim), 0.2 l dCTP, and syringe. The needle was left inserted in the cyst for the duration and a final MgCl2 concentration of 1.5 mM. of the washing and incubation steps. The cavity of intact cysts was Heteroduplex analysis was performed using Hydrolink Mutation rinsed a minimum of three times with Ca 2ϩ -and Mg 2ϩ -free PBS. The Detection Enhancement gels (MDE, AT Biochem) following the last rinse from some cysts was collected and stored on ice. PBS manufacturer's protocol. Urea was added to the gel to a final concontaining 2 mM EDTA was then injected into the lumen of the intact centration of 15% to minimize band broadening. The radiolabeled cyst. After a 20 min incubation, the cyst was massaged several times PCR products were initially denatured by heating at 95ЊC for 5 minto assist in detachment of the epithelial cells from the basement utes and then allowed to cool to room temperature gradually over membrane. Cysts that maintained the extraction solution (PBS/ 1-2 hr before loading. Gels were run at 700 V for 14-16 hr, dried, EDTA) in their lumina for the duration of the incubation period were and placed on X-Omat XAR film (Kodak) at room temperature or on considered intact. Only the epithelial cells of intact cysts were hara Phosphoimager cassette (Molecular Dynamics). vested by drainage. The cystic epithelial cells in the extraction solution (PBS/EDTA) and the last wash solutions were centrifuged at 1500 rpm (Beckman) for 15 min. The pellet was used for DNA prepaMixing Studies ration using the Puregene DNA extraction kit (Gentra) according to
The polymorphic locus EJ1 was identified by heteroduplex analysis the manufacturer's protocol. To assist in DNA precipitation, 10 g using the primers FQF28-FQR35 as described above. This PCR of glycogen was added to each sample. product spans part of exons 45 and 46 as well as the 90 bp intron between them and contains the coiled-coil domain of polycystin. Three heteroduplex patterns were detected in a screen of 20 normal Clonality Assay The DNA samples were digested with 10 units of HpaII or HhaI in and 45 affected individuals. The PCR products that gave each pattern were cloned into pCRII (Invitrogen) and then sequenced to a volume of 10 l overnight at 37ЊC. The enzyme was inactivated by heating at 95ЊC for 10 min and then used directly as template determine the molecular basis for the polymorphism. A1 was found to contain the published sequence (HUMPKD1A, GenBank accesfor PCR amplification. A set of control amplifications without prior restriction digestion was done in parallel using identical reaction sion number L33243), whereas A2 had a conservative base pair change (C-to-T) at position 12,617, which did not alter the amino conditions for samples from donors JHU93, JHU188, JHU244, and JHU304. In all cases, two alleles were amplified from each sample.
acid sequence (leucine, amino acid 4136). A3 had eight consecutive guanines in intron 45 instead of the seven contained in the published PCR was performed for 28 cycles of 94ЊC for 20 sec, 65ЊC for 20 sec, and 72ЊC for 20 sec after an initial denaturation at 94Њ for 5 genomic sequence (51, 331 ; HUMPKD1GEN, GenBank accession number L39891). All three alleles were used for mixing minutes. The PCR mixture (40 l) contained a final concentration of 10 mM of each androgen receptor primer (AR1 and AR2), 5 nM studies. EJ1 was amplified from clones of each of the alleles using the 32 P-end-labeled AR1, 2 units of Taq DNA polymerase (Bio-Rad Laboratories), and 2 mM MgCl 2. The sequences of the primers were PCR conditions described above. Four microliters of radiolabeled EJ1 amplifed using cyst DNA as template was mixed in separate obtained from sequences reported by Tilley et al. (1989) : AR1, 5Ј-GCTGTGAAGGTTGCTGTTCCTCAT-3Ј (bp 485-508; HUMARA, tubes with 4 l of cold product derived from each of the three cloned alleles. Heteroduplex analysis was performed as described above. GenBank accession number M21748), and AR2, 5Ј-TCCAGAATCTG TTCCAGAGCGTGC-3Ј (bp 230-253). The PCR products were diluted
The products obtained using sample C12 as template were cloned into pCRII and assayed using A1-A2 in mixing studies. Two indepenwith 5ϫ volume of sequencing loading buffer (95% formamide, 10 mM EDTA [pH 8.0], 0.1% bromophenol blue, and 0.1% xylene cyanol dent clones containing the mutant allele were sequenced using an automated sequencer (Applied Biosystems, Inc.) and standard FF) and separated in a 6% denaturing polyacrylamide gel. The dried gel was examined by autoradiography using X-Omat XAR film (Koprotocols. The 2 bp deletion identified in the C12 mutant clones created a dak) at Ϫ80ЊC overnight with an intensifying screen. An aliquot of DNA from a male with a different number of CAG repeats at the new MwoI site. To test for the presence of this site, a nested 172 bp PCR product was amplified using primers C12F1 (5Ј-CTC androgen receptor locus (so that the alleles could be distinguished) (1995) . Autosomal domiextension of 68ЊC for 10 min. The 1.6 kb products were cloned into nant polycystic kidney disease-evidence for the existence of a third pCRII, and then individual clones were analyzed for the variants locus in a Portuguese family. Hum. Genet. 96, 83-88. they contained at each locus using the microsatellite assay (KG8)
The European Polycystic Kidney Disease Consortium (1994). The and mixing studies (EJ1) as described above.
polycystic kidney disease gene encodes a 14 kb transcript and lies Family members of patients donating kidneys were recruited to within a duplicated region on chromosome 16. (1994) . Is there evidence for anticipation in autosomal-dominant polycystic kidney diesease? 66ЊC. Blots were washed two or three times at 65ЊC with 0.1% SSC, 0.1% SDS and imaged using a Phosphoimager screen (Molecular Kidney Int. 45, 1153-1162. Dyanamics).
Foster, K., Prowse, A., van den Berg, A., Fleming, S., Hulsbeek, Two-point linkage analyses were performed using the MLINK pro-M. M., Crossey, P.A., Richards, F.M., Cairns, P., Affara, N.A., Fergugram of the LINKAGE 5.1 package. The disease gene frequency son-Smith, M. A., et al. (1994) . Somatic mutations of the von Hippelwas set at 0.001 and penetrance set at 0.98 for individuals >30
Lindau disease tumour suppressor gene in non-familial clear cell years old. Sex-averaged recombination fractions were used (0.05 renal carcinoma. Hum. Mol. Genet. 3, 2169-2173. for 3ЈHVR and 0.0 for KG8). The posterior probability of linkage to Gabow, P.A (1993) . Autosomal dominant polycystic kidney disease. PKD1 was determined for pedigree 1 ( Figure 5A ) using an estimate N. Engl. J. Med. 329, 332-342. of the prior probability of linkage (␣) of 0.85 (Narod, 1991; Gilliland, D.G., Blanchard, K.L., Levy, J., Perrin, S., and Bunn, H.F. Sandkuijl, 1992; Ravine et al., 1992; Peters et al., 1993; Mochizuki et (1991) . Clonality in myeloproliferative disorders: analysis by means al. , 1996) . of the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 88, 6848-6852.
